Search Results - "Ranganathan, Prabha"

Refine Results
  1. 1

    An update on methotrexate pharmacogenetics in rheumatoid arthritis by Ranganathan, Prabha

    Published in Pharmacogenomics (01-04-2008)
    “…Rheumatoid arthritis (RA) is a systemic inflammatory disorder that mainly affects the joints. When left untreated, the disease can result in irreversible joint…”
    Get more information
    Journal Article
  2. 2

    Methotrexate pharmacogenetics in rheumatoid arthritis: a status report by Malik, Fardina, Ranganathan, Prabha

    Published in Pharmacogenomics (01-02-2013)
    “…Methotrexate (MTX), an antifolate drug, is the first-line disease-modifying agent for the treatment of rheumatoid arthritis (RA) worldwide. MTX has excellent…”
    Get more information
    Journal Article
  3. 3

    Development and validation of lupus nephritis case definitions using United States veterans affairs electronic health records by Li, Tingting, Lee, Iris, Jayakumar, Divya, Huang, Xinliang, Xie, Yan, Eisen, Seth, Ranganathan, Prabha

    Published in Lupus (01-03-2021)
    “…Objective International Classification of Diseases (ICD) codes are commonly used to identify patients with rare diseases in electronic health records (EHRs)…”
    Get full text
    Journal Article
  4. 4

    Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis by RANGANATHAN, Prabha, CULVERHOUSE, Robert, MARSH, Sharon, MODY, Ami, SCOTT-HORTON, Tiffany J, BRASINGTON, Richard, JOSEPH, Amy, REDDY, Virginia, EISEN, Seth, MCLEOD, Howard L

    Published in Journal of rheumatology (01-04-2008)
    “…OBJECTIVE: Research has examined the association of folate-dependent gene polymorphisms with methotrexate (MTX) toxicity in racially homogenous patients with…”
    Get full text
    Journal Article
  5. 5

    Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis by Phillips, Christopher, Zeringue, Angelique L, McDonald, Jay R, Eisen, Seth A, Ranganathan, Prabha

    Published in PloS one (23-11-2015)
    “…The objective of this retrospective cohort study was to determine the effect of tumor necrosis factor inhibitor (TNFi) therapy on the risk of head and neck…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Neoplastic and Paraneoplastic Vasculitis, Vasculopathy, and Hypercoagulability by Park, Hyon Ju, MD, Ranganathan, Prabha, MD, MS

    “…Rheumatologists are often consulted regarding both typical and atypical vasculitides, vasculopathies, and hypercoagulability. It is important to keep in mind…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Immunologic rheumatic disorders by Joseph, Amy, MD, Brasington, Richard, MD, Kahl, Leslie, MD, Ranganathan, Prabha, MD, Cheng, Tammy P., MD, Atkinson, John, MD

    Published in Journal of allergy and clinical immunology (01-02-2010)
    “…We provide the basics for clinicians who might be called on to consider the diagnosis of diseases such as systemic lupus erythematosus (SLE) or rheumatoid…”
    Get full text
    Journal Article
  10. 10

    Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis by Vijayan, Anitha, Ranganathan, Prabha, Gaut, Joseph P., Idris, Fahd, Paley, Michael A.

    “…Hydralazine is a commonly used anti-hypertensive medication. It can, however, contribute to the development of autoimmunity, in the form of drug-induced lupus…”
    Get full text
    Journal Article
  11. 11

    Biomarkers of response to TNF inhibition in RA by Ranganathan, Prabha

    Published in Nature reviews. Rheumatology (01-08-2015)
    “…The quest for new biomarkers of response to therapies in rheumatoid arthritis (RA), particularly to TNF inhibitors, continues. Two recent studies add to this…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Pharmacogenetics of therapies in rheumatoid arthritis: An update by Babiker-Mohamed, Mohamed H., Bhandari, Sambhawana, Ranganathan, Prabha

    “…Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory arthritis. Despite many treatment advances, achieving remission or low-disease activity in RA…”
    Get full text
    Journal Article